ACE and angioedema: In other words, since the more complete or sustained ACE inhibition seen with the longer-acting agents may be detrimental33, DPP-4Is are suggested to inhibit ACEs for a longer-acting duration and also be more likely to cause angioedema than shorter-acting agents.